CoChat
Sign Up
Cited by 29

The DOI matches its Crossref record.

CleavPredict: A platform for reasoning about matrix metalloproteinases proteolytic events.

Kumar, Sonu, Ratnikov, Boris I., Kazanov, Marat D., Smith, Jeffrey W., Cieplak, Piotr·2015·PLOS ONE
DOI 10.1371/journal.pone.0127877PMC PMC4440711
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0127877

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 82

  1. C Lopez-Otin, 2008, Proteases: multifunctional enzymes in life and disease, J Biol Chem, 283, 30433, 10.1074/jbc.R800035200 · DOI
  2. AA Belushkin, 2014, Sequence-derived structural features driving proteolytic processing, Proteomics, 14, 42, 10.1002/pmic.201300416 · DOI
  3. Y Igarashi, 2007, CutDB: a proteolytic event database, Nucleic acids research, 35, D546, 10.1093/nar/gkl813 · DOI
  4. S Lopez-Aviles, 2010, Cell cycle: the art of multi-tasking. Current biology, CB, 20, R101
  5. A Churg, 2012, Series "matrix metalloproteinases in lung health and disease": Matrix metalloproteinases in COPD, The European respiratory journal: official journal of the European Society for Clinical Respiratory Physiology, 39, 197, 10.1183/09031936.00121611 · DOI
  6. DR Critchley, 2009, Smurf1 zaps the talin head, Nature cell biology, 11, 538, 10.1038/ncb0509-538 · DOI
  7. A Page-McCaw, 2007, Matrix metalloproteinases and the regulation of tissue remodelling, Nat Rev Mol Cell Biol, 8, 221, 10.1038/nrm2125 · DOI · Paper page
  8. MS Brown, 1997, The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor, Cell, 89, 331, 10.1016/S0092-8674(00)80213-5 · DOI · Paper page
  9. SR Coughlin, 2000, Thrombin signalling and protease-activated receptors, Nature, 407, 258, 10.1038/35025229 · DOI
  10. GS Salvesen, 1997, Caspases: intracellular signaling by proteolysis, Cell, 91, 443, 10.1016/S0092-8674(00)80430-4 · DOI
  11. CM Overall, 2006, Tumour microenvironment—opinion: validating matrix metalloproteinases as drug targets and anti-targets for cancer therapy, Nature reviews Cancer, 6, 227, 10.1038/nrc1821 · DOI
  12. RW Carrell, 1985, Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis, Nature, 317, 730, 10.1038/317730a0 · DOI
  13. K Holmbeck, 1999, MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover, Cell, 99, 81, 10.1016/S0092-8674(00)80064-1 · DOI · Paper page
  14. C Haass, 1999, The presenilins in Alzheimer's disease—proteolysis holds the key, Science, 286, 916, 10.1126/science.286.5441.916 · DOI · Paper page
  15. J Wuarin, 1996, Regulating S phase: CDKs, licensing and proteolysis, Cell, 85, 785, 10.1016/S0092-8674(00)81261-1 · DOI
  16. RM Buller, 1991, Poxvirus pathogenesis, Microbiol Rev, 55, 80, 10.1128/MMBR.55.1.80-122.1991 · DOI
  17. O Rossetto, 2000, Bacterial toxins with intracellular protease activity, Clin Chim Acta, 291, 189, 10.1016/S0009-8981(99)00228-4 · DOI
  18. IC Lorenz, 2006, Structure of the catalytic domain of the hepatitis C virus NS2-3 protease, Nature, 442, 831, 10.1038/nature04975 · DOI
  19. LM Coussens, 2002, Matrix metalloproteinase inhibitors and cancer: trials and tribulations, Science, 295, 2387, 10.1126/science.1067100 · DOI · Paper page
  20. M Egeblad, 2002, New functions for the matrix metalloproteinases in cancer progression, Nat Rev Cancer, 2, 161, 10.1038/nrc745 · DOI · Paper page
  21. K Kessenbrock, 2010, Matrix metalloproteinases: regulators of the tumor microenvironment, Cell, 141, 52, 10.1016/j.cell.2010.03.015 · DOI · Paper page
  22. A Page-McCaw, 2007, Matrix metalloproteinases and the regulation of tissue remodelling, Nature reviews Molecular cell biology, 8, 221, 10.1038/nrm2125 · DOI · Paper page
  23. M Dziembowska, 2012, MMP9: a novel function in synaptic plasticity, The international journal of biochemistry & cell biology, 44, 709, 10.1016/j.biocel.2012.01.023 · DOI
  24. L Troeberg, 2012, Proteases involved in cartilage matrix degradation in osteoarthritis, Biochimica et biophysica acta, 1824, 133, 10.1016/j.bbapap.2011.06.020 · DOI
  25. PS Burrage, 2006, Matrix metalloproteinases: role in arthritis, Frontiers in bioscience: a journal and virtual library, 11, 529, 10.2741/1817 · DOI
  26. IK Hwang, 2004, A proteomic approach to identify substrates of matrix metalloproteinase-14 in human plasma, Biochimica et biophysica acta, 1702, 79, 10.1016/j.bbapap.2004.08.001 · DOI
  27. I Vanlaere, 2009, Matrix metalloproteinases as drug targets in infections caused by gram-negative bacteria and in septic shock, Clinical microbiology reviews, 22, 224, 10.1128/CMR.00047-08 · DOI
  28. G Murphy, 2008, Reappraising metalloproteinases in rheumatoid arthritis and osteoarthritis: destruction or repair?, Nat Clin Pract Rheumatol, 4, 128, 10.1038/ncprheum0727 · DOI
  29. W Wu, 2002, Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13, Arthritis Rheum, 46, 2087, 10.1002/art.10428 · DOI
  30. A Fraser, 2003, Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation, Arthritis Rheum, 48, 3085, 10.1002/art.11331 · DOI
  31. MW Lark, 1997, Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints, J Clin Invest, 100, 93, 10.1172/JCI119526 · DOI
  32. TL Andersen, 2004, A scrutiny of matrix metalloproteinases in osteoclasts: evidence for heterogeneity and for the presence of MMPs synthesized by other cells, Bone, 35, 1107, 10.1016/j.bone.2004.06.019 · DOI · Paper page
  33. MJ Benito, 2005, Synovial tissue inflammation in early and late osteoarthritis, Ann Rheum Dis, 64, 1263, 10.1136/ard.2004.025270 · DOI
  34. Z Zhou, 2000, Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I, Proc Natl Acad Sci U S A, 97, 4052, 10.1073/pnas.060037197 · DOI · Paper page
  35. T Kato, 2001, Diminished corneal angiogenesis in gelatinase A-deficient mice, FEBS Lett, 508, 187, 10.1016/S0014-5793(01)02897-6 · DOI
  36. V Lambert, 2003, MMP-2 and MMP-9 synergize in promoting choroidal neovascularization, FASEB J, 17, 2290, 10.1096/fj.03-0113fje · DOI
  37. D Hanahan, 1996, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86, 353, 10.1016/S0092-8674(00)80108-7 · DOI · Paper page
  38. JC Rodriguez-Manzaneque, 2001, Thrombospondin-1 suppresses spontaneous tumor growth and inhibits activation of matrix metalloproteinase-9 and mobilization of vascular endothelial growth factor, Proc Natl Acad Sci U S A, 98, 12485, 10.1073/pnas.171460498 · DOI
  39. J Oh, 2001, The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis, Cell, 107, 789, 10.1016/S0092-8674(01)00597-9 · DOI · Paper page
  40. DC Martin, 1999, Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis, Lab Invest, 79, 225
  41. H Li, 2001, AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice, Hum Gene Ther, 12, 515, 10.1089/104303401300042429 · DOI
  42. C Gatto, 1999, BAY 12–9566, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity, Clin Cancer Res, 5, 3603
  43. AC Newby, 2005, Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture, Physiol Rev, 85, 1, 10.1152/physrev.00048.2003 · DOI · Paper page
  44. AC Newby, 2007, Metalloproteinases and vulnerable atherosclerotic plaques, Trends Cardiovasc Med, 17, 253, 10.1016/j.tcm.2007.09.001 · DOI
  45. JM Shipley, 1996, Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice, Proc Natl Acad Sci U S A, 93, 3942, 10.1073/pnas.93.9.3942 · DOI · Paper page
  46. JL Johnson, 2006, Suppression of atherosclerotic plaque progression and instability by tissue inhibitor of metalloproteinase-2: involvement of macrophage migration and apoptosis, Circulation, 113, 2435, 10.1161/CIRCULATIONAHA.106.613281 · DOI
  47. JL Johnson, 2006, Effect of broad-spectrum matrix metalloproteinase inhibition on atherosclerotic plaque stability, Cardiovasc Res, 71, 586, 10.1016/j.cardiores.2006.05.009 · DOI
  48. MS Pepper, 2001, Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis, Arterioscler Thromb Vasc Biol, 21, 1104, 10.1161/hq0701.093685 · DOI
  49. AC Newby, 2006, Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates, Cardiovasc Res, 69, 614, 10.1016/j.cardiores.2005.08.002 · DOI
  50. GS Butler, 2009, Proteomic identification of multitasking proteins in unexpected locations complicates drug targeting, Nat Rev Drug Discov, 8, 935, 10.1038/nrd2945 · DOI
  51. GS Butler, 2009, Updated biological roles for matrix metalloproteinases and new "intracellular" substrates revealed by degradomics, Biochemistry, 48, 10830, 10.1021/bi901656f · DOI
  52. B Ratnikov, 2009, High throughput substrate phage display for protease profiling, Methods Mol Biol, 539, 93, 10.1007/978-1-60327-003-8_6 · DOI
  53. BI Ratnikov, 2014, Basis for substrate recognition and distinction by matrix metalloproteinases, Proc Natl Acad Sci U S A, 111, E4148, 10.1073/pnas.1406134111 · DOI
  54. MD Kazanov, 2011, Structural determinants of limited proteolysis, Journal of proteome research, 10, 3642, 10.1021/pr200271w · DOI
  55. SJ Hubbard, 1998, The structural aspects of limited proteolysis of native proteins, Biochimica et biophysica acta, 1382, 191, 10.1016/S0167-4838(97)00175-1 · DOI
  56. HM Berman, 2000, The Protein Data Bank, Nucleic Acids Res, 28, 235, 10.1093/nar/28.1.235 · DOI · Paper page
  57. VS Golubkov, 2010, The Wnt/planar cell polarity protein-tyrosine kinase-7 (PTK7) is a highly efficient proteolytic target of membrane type-1 matrix metalloproteinase: implications in cancer and embryogenesis, J Biol Chem, 285, 35740, 10.1074/jbc.M110.165159 · DOI
  58. VS Golubkov, 2010, Internal cleavages of the autoinhibitory prodomain are required for membrane type 1 matrix metalloproteinase activation, although furin cleavage alone generates inactive proteinase, The Journal of biological chemistry, 285, 27726, 10.1074/jbc.M110.135442 · DOI
  59. SA Shiryaev, 2009, Matrix metalloproteinase proteolysis of the myelin basic protein isoforms is a source of immunogenic peptides in autoimmune multiple sclerosis, PloS one, 4, e4952, 10.1371/journal.pone.0004952 · DOI
  60. SA Shiryaev, 2011, Matrix metalloproteinase proteolysis of the mycobacterial HSP65 protein as a potential source of immunogenic peptides in human tuberculosis, Febs J, 278, 3277, 10.1111/j.1742-4658.2011.08244.x · DOI
  61. SA Shiryaev, 2009, Inflammatory proprotein convertase-matrix metalloproteinase proteolytic pathway in antigen-presenting cells as a step to autoimmune multiple sclerosis, The Journal of biological chemistry, 284, 30615, 10.1074/jbc.M109.041244 · DOI
  62. J Song, 2012, PROSPER: an integrated feature-based tool for predicting protease substrate cleavage sites, PloS one, 7, e50300, 10.1371/journal.pone.0050300 · DOI
  63. I Schechter, 1967, On the size of the active site in proteases. I. Papain. 1967, Biochemical and biophysical research communications, 425, 497
  64. A Prudova, 2010, Multiplex N-terminome analysis of MMP-2 and MMP-9 substrate degradomes by iTRAQ-TAILS quantitative proteomics. Molecular & cellular proteomics, MCP, 9, 894
  65. O Schilling, 2008, Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites, Nat Biotechnol, 26, 685, 10.1038/nbt1408 · DOI
  66. JA Cuff, 2000, Application of multiple sequence alignment profiles to improve protein secondary structure prediction, Proteins, 40, 502, 10.1002/1097-0134(20000815)40:3<502::AID-PROT170>3.0.CO;2-Q · DOI
  67. JJ Ward, 2004, The DISOPRED server for the prediction of protein disorder, Bioinformatics, 20, 2138, 10.1093/bioinformatics/bth195 · DOI
  68. RP Joosten, 2011, A series of PDB related databases for everyday needs, Nucleic Acids Res, 39, D411, 10.1093/nar/gkq1105 · DOI
  69. W Kabsch, 1983, Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features, Biopolymers, 22, 2577, 10.1002/bip.360221211 · DOI · Paper page
  70. TN Petersen, 2011, SignalP 4.0: discriminating signal peptides from transmembrane regions, Nat Methods, 8, 785, 10.1038/nmeth.1701 · DOI · Paper page
  71. A Krogh, 2001, Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes, J Mol Biol, 305, 567, 10.1006/jmbi.2000.4315 · DOI · Paper page
  72. T Obayashi, 2013, COXPRESdb: a database of comparative gene coexpression networks of eleven species for mammals, Nucleic Acids Res, 41, D1014, 10.1093/nar/gks1014 · DOI
  73. A Calderone, 2013, mentha: a resource for browsing integrated protein-interaction networks, Nat Methods, 10, 690, 10.1038/nmeth.2561 · DOI
  74. M Magrane, 2011, UniProt Knowledgebase: a hub of integrated protein data, Database (Oxford), 2011, bar009, 10.1093/database/bar009 · DOI
  75. YL Yip, 2004, The Swiss-Prot variant page and the ModSNP database: a resource for sequence and structure information on human protein variants, Hum Mutat, 23, 464, 10.1002/humu.20021 · DOI
  76. CT Lu, 2013, DbPTM 3.0: an informative resource for investigating substrate site specificity and functional association of protein post-translational modifications, Nucleic Acids Res, 41, D295
  77. AC Martin, 2005, Mapping PDB chains to UniProtKB entries, Bioinformatics, 21, 4297, 10.1093/bioinformatics/bti694 · DOI
  78. ND Rawlings, 2014, MEROPS: the database of proteolytic enzymes, their substrates and inhibitors, Nucleic acids research, 42, D503, 10.1093/nar/gkt953 · DOI
  79. SA Shiryaev, 2013, High-resolution analysis and functional mapping of cleavage sites and substrate proteins of furin in the human proteome, PloS one, 8, e54290, 10.1371/journal.pone.0054290 · DOI
  80. SA Shiryaev, 2013, Substrate cleavage profiling suggests a distinct function of Bacteroides fragilis metalloproteinases (fragilysin and metalloproteinase II) at the microbiome-inflammation-cancer interface, The Journal of biological chemistry, 288, 34956, 10.1074/jbc.M113.516153 · DOI
  81. SA Shiryaev, 2012, New details of HCV NS3/4A proteinase functionality revealed by a high-throughput cleavage assay, PloS one, 7, e35759, 10.1371/journal.pone.0035759 · DOI
  82. GE Crooks, 2004, WebLogo: a sequence logo generator, Genome Res, 14, 1188, 10.1101/gr.849004 · DOI

Cited by

Sorted by citations

Metadata

Authors
Kumar, S., Ratnikov, B. I., Kazanov, M. D., Smith, J. W., & Cieplak, P.
Venue
PLOS ONE
Publisher
Public Library of Science (PLoS)
Published
2015-05-21
Volume
10
Issue
5
Pages
e0127877
ISSN
1932-6203
DOI
10.1371/journal.pone.0127877
PMC
PMC4440711
Cited by
29
References
0
Language
en
Update notices
correction (2015-06-25)
Licence
creativecommons.org/licenses/by/4.0/ (vor)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review